| 000 | 01163 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513050510.0 | ||
| 264 | 0 | _c19950407 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0300-7995 | ||
| 024 | 7 |
_a10.1185/03007999409110483 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDanese, C | |
| 245 | 0 | 0 |
_aLong-term thymopentin treatment in systemic scleroderma. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _c1994 |
||
| 300 |
_a195-201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aThymopentin _xadministration & dosage |
| 700 | 1 | _aZavattaro, E | |
| 700 | 1 | _aCalisi, L | |
| 700 | 1 | _aMarcianò, F | |
| 700 | 1 | _aPerego, M A | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 13 _gno. 4 _gp. 195-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007999409110483 _zAvailable from publisher's website |
| 999 |
_c7882034 _d7882034 |
||